Handa Pharmaceuticals is a company that develops and commercializes prescription medications. It provides its proprietary therapeutics that address significant unmet patient needs and high-barrier-to-entry generic drugs. In addition, the company develops the ONCORE technology platform aiming to create a new class of clinically differentiated tyrosine kinase inhibitors (TKIs) for oncology indications.